Aurobindo Pharma Ltd - Company Profile

Q: Who are the current directors of Aurobindo Pharma Ltd?

The current directors of Aurobindo Pharma Ltd are Adi Reddy Baddigam, Santanu Mukherjee, Deepali Pant Rajeev Joshi, Nityananda Reddy Kambam, Madan Mohan Reddy Mettu, Venkata Ramprasad Reddy Penaka, Satakarni Makkapati, Girish Paman Vanvari, Santhanam Subramanian, Mr B Adi Reddy, Sarath Chandra Reddy Penaka, Mangalam Ramasubramanian Kumar, Mr Ssubramanian, Santhanam Subramanian, Adi Reddy Baddigam.

It is a pharma public limited company based in Hyderabad, Telangana, India, established in 1986.

1986 Hyderabad, Telangana, India Active

Last Updated: December 20, 2025

Access Report

About Aurobindo Pharma Ltd

Aurobindo Pharma Ltd, a active public limited company, was established on 26 December 1986 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24239TG1986PLC015190. Registered under ROC Roc Hyderabad. it is listed on BSE: 524804 and NSE: AUROPHARMA. It has an authorized capital of ₹666.40 Cr and a paid-up capital of ₹58.08 Cr.

Formerly known as Aurobindo Pharma Pvt Ltd. It upholds a compliant status. In 2024, it reported revenue of ₹11,261.70 Cr and a net worth of ₹19,722.82 Cr. Employing 15,925 professional, Its leadership includes Adi Reddy Baddigam (Nodal Officer), Santanu Mukherjee (Director), Deepali Pant Rajeev Joshi (Director). Past directors included Channa Reddy C, Ravindra Yogesh Shenoy, Rangaswamy Rathakrishnan Iyer. It holds ₹2,000.00 Cr open charges and ₹4,387.54 Cr settled loans. Its latest AGM occurred on 10 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.2, Maithrivihar, Behind Maithri Vanam, Ameerpet,, Hyderabad, Telangana, 500038.

Company Details

CIN/LLPIN
L24239TG1986PLC015190
Registration Number
015190
Incorporation Date
26 December 1986
Authorized Capital
₹666.40 Cr
Paid-Up Capital
₹58.08 Cr
ROC Code
Roc Hyderabad
Listing Status
Listed (BSE: 524804, NSE: AUROPHARMA)
Company Status
Active

Key Metrics

Authorised Capital ₹ 666.40 Cr as on 20-12-2025
Paid Up Capital ₹ 58.08 Cr as on 20-12-2025
Company Age 39 Year, 6 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 2,000.00 Cr as on 20-12-2025
Satisfied Charges ₹ 4,387.54 Cr as on 20-12-2025
Revenue Growth **** -14.85% (FY 2024)
Profit Growth **** 58.82% (FY 2024)
Ebitda **** 28.49% (FY 2024)
Net Worth 10.10% (FY 2024)
Total Assets **** 0.88% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Aurobindo Pharma Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Aurobindo Pharma Ltd?

Current Directors

Name	Designation	Appointment Date	Status
Adi Reddy Baddigam	Nodal Officer	03 Sep 2019	Current
Santanu Mukherjee	Director	09 Feb 2023	Current
Deepali Pant Rajeev Joshi	Director	10 Feb 2024	Current
Nityananda Reddy Kambam	Managing Director	30 Dec 1992	Current
Madan Mohan Reddy Mettu	Whole-Time Director	01 Jan 2013	Current
Venkata Ramprasad Reddy Penaka	Director	30 Dec 1992	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	07 Aug 2012	Past
Pramod Abcsdd	Additional Director	01 Jun 2012	Past
Pramod Abcsdd	Additional Director	31 Aug 2017	Past
Pramod Abcsdd	Additional Director	31 Mar 2023	Past
Pramod Abcsdd	Director	29 Aug 2018	Past
Pramod Abcsdd	Managing Director	01 Jan 2022	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aurobindo Pharma.

Aurobindo Pharma Ltd, for the financial year ended 2024, experienced significant reduction in revenue, with a 14.85% decrease. The company also saw a substantial improvement in profitability, with a 58.82% increase in profit. The company's net worth Soared by an impressive increase of 10.1%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-14.85%

*******

Revenue from Operations

*******

-16.78%

*******

Total Assets

*******

0.88%

*******

Profit or Loss

*******

58.82%

*******

Net Worth

*******

10.10%

*******

EBITDA

*******

28.49%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aurobindo Pharma?

In 2024, Aurobindo Pharma had a promoter holding of 51.84% and a public holding of 48.18%. The company had 17 Subsidiaries, 2 Joint Ventures and 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹20,000,000,000.00

Satisfied Charges

₹43,875,437,500.00

Charges Breakdown by Lending Institutions

State Bank Of India : 2000.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
05 Jun 1997	State Bank Of India	₹2,000.00 Cr	Open
08 Jan 2013	Dbs Bank Ltd	₹164.00 Cr	Satisfied
25 May 2012	Ifci Limited	₹156.00 Cr	Satisfied
25 May 2012	Ifci Limited	₹130.00 Cr	Satisfied
28 Feb 2011	Axis Bank Limited	₹37.98 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Aurobindo Pharma?

Aurobindo Pharma has a workforce of 15925 employees as of Aug 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Aurobindo Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurobindo Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aurobindo Pharma

Recent Activity within the Organization

Annual General Meeting

The activity Aurobindo Pharma Ltd last Annual general meeting of members was held on 10 Sep 2025 as per latest MCA records. was completed.
10 Sep 2025
Balance Sheet

The activity Aurobindo Pharma Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.
31 Mar 2025
Director Appointment

The activity Mangalam Ramasubramanian Kumar was appointed as a Director was appointed as a Director on 01 Apr 2024 & has been associated with this company since 2 years 3 months . was completed.
01 Apr 2024
Director Appointment

Deepali Pant Rajeev Joshi was appointed as a Director was appointed as a Director on 10 Feb 2024 & has been associated with this company since 2 years 4 months . was recorded as a recent event.
10 Feb 2024
Director Appointment

The activity Satakarni Makkapati was appointed as a Director was appointed as a Director on 09 Nov 2023 & has been associated with this company since 2 years 7 months . was completed.
09 Nov 2023
Charges

Progress on A charge with State Bank Of India of Rs. 2,000.00 Cr registered on 05 Jun 1997 with Charge ID 80013576 was modified on 22 Feb 2023. was documented.
22 Feb 2023

Explore recent activity and updates - View Recent Activity